Network Insights Methodology Whitepaper Get Access

Novartis

ORG Health Care / Pharmaceuticals Momentum 10.2ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

$56.7B revenue (2025), Basel-based Novartis operates one of the world's largest integrated pharma and gene therapy platforms. Recent domestic partnership announcements signal manufacturing capacity expansion in the US.

Novartis partnering with Nucor and US Forged Rings on domestic investment expansion initiatives
-0.41
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
10.2
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
23
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
Novartis is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Connected Entities
Merck China European Union PlocamiumAI United States Anthropic AstraZeneca CEO North Carolina Eli Lilly Texas DOD Senator Germany United Kingdom
Watch This Entity
PSI Intelligence
30-Day Trend
2026-06-05 2026-07-05 27 0 Degree Mentions
Signal Decomposition
Attention Cascade
0.236
Narrative Drift
0.095
Spectral Shift
635.712
Sentiment-Momentum Divergence
0.000
Source Concentration
0.800
Signal
Novartis is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Driver
Ranked #37 of 77 in Health Care — in line with sector peers. PSI stable vs yesterday (-0.48).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
37 of 77
Sector Rank
+0.05
Peer Z-Score
53%
Sector Percentile
Network Analysis
23 Degree Centrality
Ego Network (top connections)
Merck (weight 109.0)China (weight 7.0)European Union (weight 7.0)PlocamiumAI (weight 7.0)United States (weight 7.0)Anthropic (weight 5.0)AstraZeneca (weight 4.0)CEO (weight 4.0) MerckChinaEuropean UnionPlocamiumAIUnited StatesAnthropicAstraZenecaCEO Novartis (degree 23) Novartis
Centrality History
2026-06-05 2026-07-05 27 0 Degree Mentions
EntityWeight StatusFirst Seen
Merck 109 NEW
China 7 NEW
European Union 7 NEW
PlocamiumAI 7 NEW
United States 7 NEW
Anthropic 5 NEW
AstraZeneca 4 NEW
CEO 4 NEW
North Carolina 4 NEW
Eli Lilly 3 NEW
Texas 3 NEW
DOD 3 NEW
Senator 2 NEW
Germany 2 NEW
United Kingdom 2 NEW
Boeing 2 NEW
Intel 2 NEW
Ohio 2 NEW
SEC 2 NEW
TSMC 2 NEW
FDA 2 NEW
Airbus 2 NEW
Asia 2 NEW
Article Coverage (0)
DateLaneTitle
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-07-05 ← Intelligence Network